Raising Capital | Using Debt versus Equity Financing for early-stage Biotech and Life Sciences companies

Tuesday, Apr 9, 2024

At a time when raising capital may be challenging, Life Sciences and Biotech startups & early-growth stage companies should evaluate debt financing, a form of capital that is more traditionally used by early-stage tech companies or companies generating steady streams of cash flows.   During a panel discussion with our seasoned experts, we will reflect on:

  • Is debt financing the right instrument to grow your biotech or life sciences company?
  • When should life sciences/biotech startups and early-growth stage companies consider debt financing?
  • What are the pros and cons of raising debt versus equity?
  • What financing structures are available?

The panel discussion will be preceded by a tour of the Smartlabs facilities at Boston LandingJoin us at 5pm to learn how they deliver flexible turnkey lab programs to support workflows at every stage of development.

This event is supported by KeyBank.

Date: Tuesday, April 9, 2024

  • 5 pm – Private tour of SmartLabs state-of-the-art facilities
  • 6 pm – Panel Discussion, followed by networking cocktail

Location: Smartlabs, (3rd floor) 40 Guest St, 02135, Boston, (directions), onsite parking available (access behind the building)
Registration:  $32 for GABC members | $47 for non-members

This event is organized by FACCNE. Please use their registration link to register. Select “GABC member” when checking out to receive the member price.